BACKGROUND/AIMS: Atherosclerosis, coronary artery calcification, diabetes mellitus, inflammation, endothelial dysfunction, and left ventricular hypertrophy are the most commonly encountered risk factors in the pathogenesis of cardiovascular disease in end-stage renal disease (ESRD) patients. Epicardial adipose tissue (EAT) is the true visceral fat depot of the heart. The relationship between coronary artery disease (CAD) and EAT was shown in healthy subjects and patients with high risk of CAD. To date, there is not enough data about EAT in diabetic and nondiabetic ESRD patients. Therefore, we aimed to investigate the EAT and coronary artery calcification score (CACS) in diabetic and nondiabetic ESRD patients and healthy subjects. METHODS: Sixty ESRD patients (17 diabetic, 43 nondiabetic ESRD patients) and 20 healthy subjects were enrolled in the study. EAT and CACS were performed by a 64-slice multidetector computed tomography scanner. RESULTS: There were no differences in age, gender, body mass index, predialysis systolic and diastolic blood pressure levels, biochemical parameters including serum low-density lipoprotein and high-density lipoprotein cholesterol, triglycerides, and C-reactive protein between healthy subjects, diabetic, and nondiabetic ESRD patients. Total CACSs and EAT measurements were significantly higher in diabetic ESRD patients when compared with nondiabetic ESRD patients and healthy subjects. There was statistically significant relationship between EAT and CACS in ESRD patients (p < 0.0001, r = 0.48). CONCLUSION: In conclusion, we found a significant increase in terms of EAT and CACS in diabetic ESRD patients when compared with nondiabetic ESRD patients and healthy subjects.
BACKGROUND/AIMS: Atherosclerosis, coronary artery calcification, diabetes mellitus, inflammation, endothelial dysfunction, and left ventricular hypertrophy are the most commonly encountered risk factors in the pathogenesis of cardiovascular disease in end-stage renal disease (ESRD) patients. Epicardial adipose tissue (EAT) is the true visceral fat depot of the heart. The relationship between coronary artery disease (CAD) and EAT was shown in healthy subjects and patients with high risk of CAD. To date, there is not enough data about EAT in diabetic and nondiabetic ESRDpatients. Therefore, we aimed to investigate the EAT and coronary artery calcification score (CACS) in diabetic and nondiabetic ESRDpatients and healthy subjects. METHODS: Sixty ESRDpatients (17 diabetic, 43 nondiabetic ESRDpatients) and 20 healthy subjects were enrolled in the study. EAT and CACS were performed by a 64-slice multidetector computed tomography scanner. RESULTS: There were no differences in age, gender, body mass index, predialysis systolic and diastolic blood pressure levels, biochemical parameters including serum low-density lipoprotein and high-density lipoprotein cholesterol, triglycerides, and C-reactive protein between healthy subjects, diabetic, and nondiabetic ESRDpatients. Total CACSs and EAT measurements were significantly higher in diabetic ESRDpatients when compared with nondiabetic ESRDpatients and healthy subjects. There was statistically significant relationship between EAT and CACS in ESRDpatients (p < 0.0001, r = 0.48). CONCLUSION: In conclusion, we found a significant increase in terms of EAT and CACS in diabetic ESRDpatients when compared with nondiabetic ESRDpatients and healthy subjects.
Authors: Turgay Saritas; Sebastian Daniel Reinartz; Jennifer Nadal; Jonas Schmoee; Matthias Schmid; Mohamed Marwan; Stephan Achenbach; Stefan Störk; Christoph Wanner; Kai-Uwe Eckardt; Jürgen Floege; Markus Peter Schneider; Georg Schlieper Journal: Clin Kidney J Date: 2019-04-08
Authors: K Turkmen; H Z Tonbul; F M Erdur; I Guney; H Kayikcioglu; L Altintepe; O Ozbek; M I Yilmaz; A Gaipov; S Turk; A Covic; M Kanbay Journal: Int Urol Nephrol Date: 2012-09-23 Impact factor: 2.370
Authors: Daniel Constantino Yazbek; Aluizio Barbosa Carvalho; Cinara Sa Barros; Jose Osmar Medina Pestana; Carlos Eduardo Rochitte; Raul Dias Dos Santos Filho; Maria Eugênia F Canziani Journal: PLoS One Date: 2018-02-21 Impact factor: 3.240
Authors: Jasmine D Kerr; Rachel M Holden; Alexander R Morton; Robert L Nolan; Wilma M Hopman; Cynthia M Pruss; Jocelyn S Garland Journal: BMC Nephrol Date: 2013-01-26 Impact factor: 2.388